# US 2021/0275567 A1 · Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275567 A1
- Document ID: US20210275567A1
- Status: Published application
- Kind: A1
- Application number: 17/140,295
- Filed: 2021-01-04
- Published: 2021-09-09
- Earliest claimed: 2014-09-29
- Assignees: Fred Hutchinson Cancer Research Center
- Applicants: Fred Hutchinson Cancer Research Center
- Inventors: Richard A. ZAGER; Ali CM JOHNSON
- Web page: https://patentgrep.com/patent/US20210275567A1

## CPC

- A61K 31/714: Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A01N 1/126: Physiologically active agents, e.g. antioxidants or nutrients
- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61K 31/555: containing heavy metals, e.g. hemin, hematin, melarsoprol
- A61K 33/26: Iron; Compounds thereof
- A61K 38/42: Haemoglobins; Myoglobins
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 13/12: of the kidneys
- A61P 31/04: Antibacterial agents
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07H 23/00: Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12 (esters with inorganic acids C07H11/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

The present disclosure provides compositions, kits, and methods to protect organs by inducing acquired cytoresistance without causing injury to the organ. The compositions, kits, and methods utilize heme proteins, iron and/or vitamin B12 and, optionally, agents that impact heme protein metabolism.

## Claims

### Claim 1

A method of protecting an organ of a human patient from injury based on a scheduled insult comprising administering to the organ a therapeutically effective amount of (i) iron sucrose; and (ii) vitamin B12 or a derivative thereof, the therapeutically effective amount being administered before the insult to the organ occurs.

### Claim 2 (depends on 1)

The method of claim 1, wherein the insult is a scheduled insult.

### Claim 3 (depends on 2)

The method of claim 2, wherein the scheduled insult is surgery, chemotherapy, or radiocontrast toxicity.

### Claim 4 (depends on 3)

The method of claim 3, wherein the surgery is an organ transplant surgery.

### Claim 5 (depends on 2)

The method of claim 2, wherein the administration occurs at least 2 hours before the scheduled insult to the organ occurs.

### Claim 6 (depends on 2)

The method of claim 2, wherein the administration occurs at least 4 hours before the scheduled insult to the organ occurs.

### Claim 7 (depends on 2)

The method of claim 2, wherein the administration occurs at least 12 hours before the scheduled insult to the organ occurs.

### Claim 8 (depends on 2)

The method of claim 2, wherein the administration occurs at least 18 hours before the scheduled insult to the organ occurs.

### Claim 9 (depends on 1)

The method of claim 1, wherein the organ is a transplanted organ.

### Claim 10 (depends on 1)

The method of claim 1, wherein the organ is a heart, kidney, liver, or lung.

### Claim 11 (depends on 1)

The method of claim 1, wherein the organ is a kidney and protection is evidenced by prevention or reduction in BUN or serum creatinine increases as compared to a reference level.

### Claim 12

A method of protecting an organ of a human patient from injury based on a scheduled insult comprising administering to the organ a therapeutically effective amount of (i) iron sucrose; and (ii) vitamin B12 or a derivative thereof, the therapeutically effective amount being administered at least 2 hours before the scheduled insult to the organ occurs.

### Claim 13 (depends on 12)

The method of claim 12, wherein the scheduled insult is surgery, chemotherapy, or radiocontrast toxicity.

### Claim 14 (depends on 13)

The method of claim 13, wherein the surgery is an organ transplant surgery.

### Claim 15 (depends on 12)

The method of claim 12, wherein the organ is a transplanted organ.

### Claim 16 (depends on 12)

The method of claim 12, wherein the organ is a heart, kidney, liver, or lung.

### Claim 17 (depends on 12)

The method of claim 12, wherein the administration occurs at least 4 hours before the scheduled insult to the organ occurs.

### Claim 18 (depends on 12)

The method of claim 12, wherein the administration occurs at least 12 hours before the scheduled insult to the organ occurs.

### Claim 19 (depends on 12)

The method of claim 12, wherein the administration occurs at least 18 hours before the scheduled insult to the organ occurs.

### Claim 20 (depends on 12)

The method of claim 12, wherein the organ is a kidney and protection is evidenced by prevention or reduction in BUN or serum creatinine increases as compared to a reference level.
